BNP Paribas Easy MSCI Europe SRI SSeries 5 Capped (ASRR) Share Price

Thanks, it sounds like they just might be paying some lawyers to work on Sunday to put the final touches on everything. If that turns out to be the case, next Monday could be exciting.

I would suspect that if this fails to happen, it will take a lot of work, but they can put it back

Thanks, it sounds like they just might be paying some lawyers to work on Sunday to put the final touches on everything. If that turns out to be the case, next Monday could be exciting.

I would suspect that if this fails to happen, it will take a lot of work, but they can put it back

twittter pump

I’m here to have debates and offer fact based opinions. I can successfully go back and forth with anyone, as I have absolute confidence in my research.
However, I can see that he is struggling mightily and likely needs a break from discussion boards, as he feels any conflicting views must

8 days is at or around 7/3. Is that the best day to put out news given the 4th is a holiday?

Trofinetide for the treatment of Rett syndrome:

The most common adverse events in LILAC were diarrhea (74.7%), vomiting (28.6%), and COVID-19 (11.0%). Diarrhea was the most common adverse event leading to treatment withdrawal (21.4%).

Compared to Anavex's blarcames

Imagine how your parents must feel. 🥺

$BTC DOWN when $USD UP!! https://stockcharts.com/freecharts/gallery.html?$USD

That's certainly positive thinking. 🤣

But I believe if Hikma thinks there is risk of multi-hundred million dollar damages (or more), they will figure out a way to settle long before that ever comes to be.

I could see them agreeing to settle by exiting the IPE m

You’re wrong again it was a Blog dedicated to patents. And those statistics are pretty simple. Won or Lost/ Denied or Instituted/ this isn’t like one of your posts were you never give VP the benefit of your doubts. Your posts are all inaccurate, you claim you know it all, but that is were you are w

Ron YOU ARE THE ONLY ONE who I trust.
What is your opinion on the amount per escrow common share and the timing?

Aren't chances of a settlement high? Given that the valuation of the company is effectively zero net of cash at the moment, a fast $100-200m settlement (as well as Hikma dropping their case) could be worth it?

It is also possible a buyer in the wings might be interested in buying Amar

I'm just the messenger. That's all they've said about it.

It's really not that hard to figure out. The key is the amended Asset Purchase Agreement (APA).

That unleashing of additional Milestone Events, and increased payments from reaching those Milestone Events, would satisfy all financial obligations to all classes of creditors, and lead t

bingo, you just won the big door prize. excellent basher analysis.

Might be your greatest post

Still 27 days to cover. I am expecting a decent covering from the last 2 weeks. Maybe 350k shares covered? WAG only. That would put us at about 11-12% of float (float is 10.9mil). At increased daily volume, that could bring the days to cover to around 18 days. That would relieve some of the sh

right

I can see this happening unfortunately .............

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/449241547_8408728369157132_4123476120671191819_n.jpg?_nc_cat=110&ccb=1-7&_nc_sid=833d8c&_nc_ohc=zksTBCjx_3EQ7kNvgHwut62&_nc_ht=scontent-sea1-1.xx&oh=00_AYB_sroCoCusCea0gNTckSfaeqiHs

French Fried....just like this sad "company."

So all the folks slapping down on people saying they thought the company could be diluting need to back off the next time someone posts that. Its not at all an obscene amount. It is staying pretty constant and not unexpected. As I posted earlier, it is looking like the company is diluting a chunk

I'm still thinking we hit 95.00 by the end of the year. Gonna stick with this prediction regardless of the possibility of being wrong.

Don't be too panicky now. The AI scanner may give you a depression alert.

🔥🩳🔥 Buckle up #APES because today's update is packed with thrilling insights into why $AMC is massively undervalued and poised for a monumental short squeeze.

With institutional manipulation, order imbalances, and the resilience of retail investors, the stage